Chemotherapy’s gut damage turns out to have a surprising upside. By changing nutrient availability in the intestine, it ...

A research team led by Professor Yuan Li at Nanjing Medical University published a research paper entitled "A Cigarette ...

Corcept Therapeutics, sponsor of the ROSELLA trial, is currently evaluating relacorilant in other solid tumors, including platinum-sensitive ovarian cancer, endometrial cancer, cervical cancer, ...

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...

Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune ...

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

Pediatric acute myeloid leukemia (AML) is one of the most common acute leukemias in children. While treatment outcomes have ...

Accountability reporting is helping reverse health policy and funding shifts tied to the HHS secretary’s agenda ...

In the evolving landscape of metastatic colorectal cancer, managing patients with RAS/BRAF wild-type tumors remains a ...